Literature DB >> 29871780

Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis.

Gokul Raj Kathamuthu1, Nathella Pavan Kumar2, Kadar Moideen3, Dhanaraj Baskaran4, Syed Hissar4, Basavegowdanadoddi M Shrinivasa4, Rathinam Sridhar5, Subash Babu6.   

Abstract

BACKGROUND: IL-10 family cytokines are associated with the host immune response to pulmonary tuberculosis (PTB), but their association with host response in tuberculous lymphadenitis (TBL) is not known.
METHODS: Hence, we examined the circulating levels of the whole panel of IL-10 family cytokines in TBL (n = 44) and compared them to the levels in PTB (n = 44) and healthy control (HC, n = 44) individuals. We also assessed the pre and post-treatment cytokine levels in TBL individuals following the completion of anti-tuberculosis treatment (ATT). Next, we also compared the levels of IL-10 family cytokine in circulation versus lymph node (LN) culture supernatants in a subset of TBL individuals (n = 22). Finally, we also measured the levels of IL-10 family cytokines in tuberculosis antigen (purified protein derivative, PPD) stimulated and unstimulated LN culture supernatants.
RESULTS: TBL individuals exhibit significantly decreased levels of IL-10, IL-19, IL-20, IL-24, IL-28B and IL-29 in the circulation when compared to PTB (except IL-10) and HC (except IL-20 and IL-28B) and significantly increased levels of IL-22 when compared to PTB individuals. Following ATT, TBL individuals exhibit significantly elevated levels of IL-10, IL-19, IL-20, IL-24, IL-28B and IL-29 and significantly diminished levels of IL-26. Similarly, TBL individuals also exhibited significantly increased levels of IL-10, IL-19, IL-20, IL-24, IL-28A and IL-29 in LN culture supernatants compared to plasma and significantly decreased levels of IL-22. This was associated with enhanced levels of IL-19, IL-20, IL-24, IL-28B and IL-29 upon PPD stimulation of LN cultures.
CONCLUSIONS: Therefore, we demonstrate that TBL is associated with significantly diminished plasma and elevated LN culture supernatant levels of most of the IL-10 family cytokines. This to our knowledge is the first comprehensive examination of IL-10 family cytokines in TBL.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; ELISA; IL-10 family; TB lymph node; Tuberculous lymphadenitis

Mesh:

Substances:

Year:  2018        PMID: 29871780      PMCID: PMC6340908          DOI: 10.1016/j.cyto.2018.05.027

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  43 in total

Review 1.  Role of IL-22 in microbial host defense.

Authors:  Celine Eidenschenk; Sascha Rutz; Oliver Liesenfeld; Wenjun Ouyang
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.

Authors:  Chung-Hsi Hsing; Hung-Chi Cheng; Yu-Hsiang Hsu; Chien-Hui Chan; Ching-Hua Yeh; Chien-Feng Li; Ming-Shi Chang
Journal:  Clin Cancer Res       Date:  2011-12-20       Impact factor: 12.531

3.  Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10).

Authors:  G Gallagher; H Dickensheets; J Eskdale; L S Izotova; O V Mirochnitchenko; J D Peat; N Vazquez; S Pestka; R P Donnelly; S V Kotenko
Journal:  Genes Immun       Date:  2000-10       Impact factor: 2.676

Review 4.  The IL-20 subfamily of cytokines--from host defence to tissue homeostasis.

Authors:  Sascha Rutz; Xiaoting Wang; Wenjun Ouyang
Journal:  Nat Rev Immunol       Date:  2014-12       Impact factor: 53.106

Review 5.  Interleukin-19: multiple roles in immune regulation and disease.

Authors:  Grant Gallagher
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

6.  Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.

Authors:  Snehlata Kumari; Marion C Bonnet; Maria H Ulvmar; Kerstin Wolk; Niki Karagianni; Ellen Witte; Claudia Uthoff-Hachenberg; Jean-Christophe Renauld; George Kollias; Rune Toftgard; Robert Sabat; Manolis Pasparakis; Ingo Haase
Journal:  Immunity       Date:  2013-11-07       Impact factor: 31.745

7.  Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.

Authors:  Ying Tian; Laura J Sommerville; Anthony Cuneo; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

8.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

9.  Extrapulmonary tuberculosis among females in South Asia-gap analysis.

Authors:  Jaishri Mehraj; Zain Yar Khan; Dania Khalid Saeed; Sadia Shakoor; Rumina Hasan
Journal:  Int J Mycobacteriol       Date:  2016-11-15

10.  Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus.

Authors:  Ian A Myles; Natalia M Fontecilla; Patricia A Valdez; Paul J Vithayathil; Shruti Naik; Yasmine Belkaid; Wenjun Ouyang; Sandip K Datta
Journal:  Nat Immunol       Date:  2013-06-23       Impact factor: 25.606

View more
  1 in total

1.  Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis.

Authors:  Heike C Hawerkamp; Lasse van Geelen; Jan Korte; Jeremy Di Domizio; Marc Swidergall; Afaque A Momin; Francisco J Guzmán-Vega; Stefan T Arold; Joachim Ernst; Michel Gilliet; Rainer Kalscheuer; Bernhard Homey; Stephan Meller
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.